GlassScriptPhysician profile
Sharon A Eshet
NPI 1114555497
$2,629.91
in general payments reported to CMS, 2019-2025
16 companies · $772 in 2025
The $772 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2023: $894 · 2024: $841 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,007 · Grant: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,007.13 |
| Grant | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $608.90 | 2023-2025 | Nucala |
| Genzyme Corporation | $547.00 | 2023-2024 | |
| Grifols USA, LLC | $319.88 | 2023-2024 | Xembify |
| Blueprint Medicines Corporation | $190.68 | 2023-2025 | Ayvakit |
| Galderma Laboratories, L.P. | $147.92 | 2025 | Nemluvio |
| Astrazeneca Pharmaceuticals LP | $146.80 | 2022-2025 | Tezspire |
| Pharming Healthcare, INC. | $145.72 | 2024-2025 | Ruconest |
| Sobi, INC | $127.50 | 2024 | |
| Csl Behring | $109.96 | 2024-2025 | Hizentra, Haegarda, Kcentra |
| Genentech USA, INC. | $79.60 | 2024-2025 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $56.10 | 2023-2025 | Takhzyro, Cuvitru |
| Phadia US INC. | $33.15 | 2023 | Immunocap |
| Novartis Pharmaceuticals Corporation | $32.43 | 2025 | |
| Amgen INC. | $32.31 | 2025 | Actimmune |
| Biocryst US Sales Co., LLC | $29.02 | 2025 | Orladeyo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $22.94 | 2025 | Odactra, Ragwitek, Grastek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Eshet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.